SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-093904
Filing Date
2020-08-12
Accepted
2020-08-12 16:16:18
Documents
4
Period of Report
2020-08-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2027384d1_8k.htm 8-K 19150
2 EXHIBIT 99.1 tm2027384d1_ex99-1.htm EX-99.1 72599
3 GRAPHIC image_002.jpg GRAPHIC 8552
4 GRAPHIC image_001.jpg GRAPHIC 5911
  Complete submission text file 0001104659-20-093904.txt   113197
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Filer) CIK: 0001130166 (see all company filings)

IRS No.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50626 | Film No.: 201095667
SIC: 2834 Pharmaceutical Preparations